Stephanie Greene

Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer

Howard I. Scher, David Lu, Nicole A. Schreiber et al. · JAMA Oncology · 2016 · 637 citations · Full text

Medicine, Oncology, Pharmacology +17

Inhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy

Susan E. Logue, Eoghan P. McGrath, Patricia A. Cleary et al. · Nature Communications · 2018 · 290 citations · Full text

Life Sciences, Molecular Biology, Oncology +16

IRE1α-XBP1s pathway promotes prostate cancer by activating c-MYC signaling

Xia Sheng, Hatice Zeynep Nenseth, Su Qu et al. · Nature Communications · 2019 · 233 citations · Full text

Life Sciences, Molecular Biology, Oncology +16

Phenotypic Heterogeneity of Circulating Tumor Cells Informs Clinical Decisions between AR Signaling Inhibitors and Taxanes in Metastatic Prostate Cancer

Howard I. Scher, Ryon P. Graf, Nicole A. Schreiber et al. · Cancer Research · 2017 · 135 citations

Medicine, Oncology, Pathology +17

Analytical Validation and Capabilities of the Epic CTC Platform: Enrichment-Free Circulating Tumour Cell Detection and Characterization

Shannon L. Werner, Ryon P. Graf, Mark Landers et al. · Journal of Circulating Biomarkers · 2015 · 127 citations · Full text

Medicine, Cancer Biology, Precision Oncology +2